Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Applicability of a "Pick a Winner" trial design to acute myeloid leukemia

Hills, Robert Kerrin and Burnett, Alan Kenneth 2011. Applicability of a "Pick a Winner" trial design to acute myeloid leukemia. Blood 118 (9) , pp. 2389-2394. 10.1182/blood-2011-02-337261

Full text not available from this repository.

Abstract

Randomized clinical trials remain the gold standard to establish efficacy and safety of new treatments. In acute myeloid leukemia, large trials have been associated with gradual improvement in outcome over 2 decades in younger patients without major differences emerging between treatments. By contrast, in older patients, improvement has been minimal, which justifies a new approach to identifying effective treatments. Given the urgent unmet need, and with the emergence of several novel agents or combinations that are likely to be expensive, large benefits are probably required to change clinical practice. To address this issue, we have evolved a “Pick a Winner” randomized progressive design with a rolling incorporation of novel treatments (drug X), which has been tested in older patients with acute myeloid leukemia. The rationale, operational characteristics, and initial experience of such an approach in the context of the United Kingdom National Cancer Research Institute AML16 trial are presented.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Publisher: American Society of Hematology
ISSN: 0006-4971
Last Modified: 19 Oct 2019 02:50
URI: http://orca-mwe.cf.ac.uk/id/eprint/28448

Citation Data

Cited 31 times in Google Scholar. View in Google Scholar

Cited 48 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item